Possible involvement of interleukin-18 in the pathology of hepatobiliary adverse effects related to treatment with ceritinib

BACKGROUND: Ceritinib demonstrated a statistically significant effect on the progression-free survival versus chemotherapy in patients with advanced anaplastic lymphoma kinase (ALK) rearrangement in non-small cell lung cancer (NSCLC) as the first therapy or after previous treatment with crizotinib a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirano, Taizou, koarai, Akira, Ichikawa, Tomohiro, Sato, Teruyuki, Ohe, Takashi, Ichinose, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194610/
https://www.ncbi.nlm.nih.gov/pubmed/30340555
http://dx.doi.org/10.1186/s12885-018-4913-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194610/
https://www.ncbi.nlm.nih.gov/pubmed/30340555
http://dx.doi.org/10.1186/s12885-018-4913-5

Ejemplares similares